1.1 Research Scope – Application of Organ-on-a-chip Technology in Drug Screening Process

1.2 Research Methodology – The Frost & Sullivan Core Value

1.3 Key Findings: Organ-on-a-chip Technology

2.1 A Brief Overview of Organ-on-a-chip Functioning

2.2 Key Factors Empowering Organ-on-a-chip Technologies for Drug Screening Processes

2.3 Current Trends in the Organ-on-a-chip platform

3.1 Heart-on-a-chip Platform

3.2 Liver-on-a-chip Platform

3.2.1 High Throughput Capability of Liver-on-a-chip Platforms Integral to Large-Scale Drug Screening Applications

3.2.2 Flow Systems Adopted in Liver-on-a-chip Platforms that Facilitate Stability

3.3 Lung-on-a-chip Platform

3.3.1 Lung-on-a-chip: Platform Overview, Application, Disadvantages and Features

3.4 Kidney-on-a-chip Platform

3.4.1 Kidney-on-a-chip: Features, Platform Design, Applications, and Challenges

3.5 Gut-on-a-chip/Intestine-on-a-chip Platform

3.5.1 Intestine- and Gut-on-a-chip Serve as Enhanced Study Models

3.5.2 Intestine- and Gut-on-a-chip: The Applications and the Challenges

3.6 Nerve-on-a-chip Platform

3.6.1 Evaluation of Neurotoxicity with Nerve-on-a-chip platform

3.7 Muscle-on-a-chip Platform

3.7.1 Muscle-on-Chip Platform to Determine Long-term rug ffects on Muscle Loss and Toxicity

3.7.2 Muscle-on-a-chipPhysiology, Features and Application Areas

3.8 Brain-on-a-chip Platform

3.8.1 Emulation of Human-Blood-Brain Barrier

3.9 Multi-Organ Chip Platforms

3.10 Human-on-a-chip Platform

4.1 Drivers and Challenges Impact Chart of Organ-Chip Technology

4.2 Organ-on-a-chip Technology

4.3 Stem ell henotypes key to unlocking vast otential of Organ-chip Systems

5.1 A Well-defined and Robust Nerve-on-a-chip Platform

5.2 CN Bio- UK’s Organ-chip Technology Pioneer

5.3 Emulate propelling Drug Screening and Development through their

5.4 Hesperos facilitates superior Serum-free Media and Pumpless Organ-Chip Systems

5.5 Liver-on-a-chip platforms with High Biological Fidelity

5.6 Scaffold-free Human Relevant Liver-on-a-Chip Systems

5.7 Validated Research-ready Organ-chip Systems

5.8 Organ-Chips that facilitate High Throughput Screening

5.9 Precise Flow-controlled ParVivo Organ-Chip Systems

5.10 Replicating In Vivo Cardiac Biology on an n Vitro Chip Platform

5.11 TissUse pioneering Human-on-a-Chip platform

6.1. Patent Research Scope and Concepts

6.2 Top 20 Patent Holders in the Organ-on-a-chip Platform

6.3 Patent Office-wise Distribution of Organ-on-a-chip Patent Portfolio, 2008–2018*

6.4 Year-wise Publication Distribution of Organ-on-a-chip Patent Portfolio, 2008–2017

7.1 Funding Strength of Organ-Chip Technology- Global View

7.2 Government Funding for Organ-on-a-chip Development

7.3 Venture Capitalist-based Investment Funding in the OOC Market

7.4.Animal Free Research involved in Funding of Organ-on-a-chip Technology Development

8.1 Growth Opportunity 1: Personalized Medicine

8.2 Growth Opportunity 2: Animal Model Replacement

8.3 Growth Opportunity 3: Identification of Biomarkers

8.4 Determinants of Organ-on-a-chip Platform’s Impact on Drug Screening Process

9.1 Key Contacts

9.1 Key Contacts (continued)

Legal Disclaimer